EUVIMEDEUVIMED entdecken
Leserbrief

Key questions remain about GLP-1 drug discontinuation

Dhanesh D Binda, Ala Nozari

BMJ · 30.03.2026 · 392 · s575

DOI: 10.1136/bmj.s575 ↗

Kurz gefasst

Leserbrief in der Zeitschrift BMJ, online erschienen am 30.03.2026. Verfasst von Dhanesh D Binda und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Montefiore Medical Center, Albert Einstein College of Medicine, NY, USA. Die Arbeit nennt 9 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Anesthesiology, Montefiore Medical Center, Albert Einstein College of Medicine, NY, USA.
  • Boston Medical Center-Brighton, Boston, MA, USA.
  • Department of Anesthesiology, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.

Zitieren

APA

Binda, D. D., & Nozari, A. (2026). Key questions remain about GLP-1 drug discontinuation. BMJ, 392, s575. https://doi.org/10.1136/bmj.s575

Vancouver

Binda DD, Nozari A. Key questions remain about GLP-1 drug discontinuation. BMJ. 2026;392:s575. doi:10.1136/bmj.s575

BibTeX
@article{Binda2026,
  author = {Binda, Dhanesh D and Nozari, Ala},
  title = {Key questions remain about GLP-1 drug discontinuation},
  journal = {BMJ},
  year = {2026},
  volume = {392},
  pages = {s575},
  doi = {10.1136/bmj.s575}
}
Kostenlos starten →